vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and Orange County Bancorp, Inc. (OBT). Click either name above to swap in a different company.
Orange County Bancorp, Inc. is the larger business by last-quarter revenue ($33.0M vs $20.0M, roughly 1.7× AGIOS PHARMACEUTICALS, INC.). Orange County Bancorp, Inc. runs the higher net margin — 37.6% vs -541.1%, a 578.7% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs 20.6%). Orange County Bancorp, Inc. produced more free cash flow last quarter ($41.3M vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs 14.3%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Orange County Bancorp, Inc. is a Delaware-registered bank holding company operating mainly in New York, U.S. It offers a full range of retail and commercial banking services, including deposit accounts, loans and wealth management solutions, serving individual consumers, small and mid-sized corporate clients in its regional footprint.
AGIO vs OBT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $33.0M |
| Net Profit | $-108.0M | $12.4M |
| Gross Margin | 90.6% | — |
| Operating Margin | -608.9% | 41.4% |
| Net Margin | -541.1% | 37.6% |
| Revenue YoY | 86.1% | 20.6% |
| Net Profit YoY | -11.9% | 73.5% |
| EPS (diluted) | $-1.86 | $0.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $33.0M | ||
| Q3 25 | $12.9M | $33.7M | ||
| Q2 25 | $12.5M | $32.5M | ||
| Q1 25 | $8.7M | $28.0M | ||
| Q4 24 | $10.7M | $27.4M | ||
| Q3 24 | $9.0M | $27.1M | ||
| Q2 24 | $8.6M | $27.9M | ||
| Q1 24 | $8.2M | $25.3M |
| Q4 25 | $-108.0M | $12.4M | ||
| Q3 25 | $-103.4M | $10.0M | ||
| Q2 25 | $-112.0M | $10.5M | ||
| Q1 25 | $-89.3M | $8.7M | ||
| Q4 24 | $-96.5M | $7.2M | ||
| Q3 24 | $947.9M | $3.2M | ||
| Q2 24 | $-96.1M | $8.2M | ||
| Q1 24 | $-81.5M | $9.3M |
| Q4 25 | 90.6% | — | ||
| Q3 25 | 87.0% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 87.6% | — | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 92.3% | — |
| Q4 25 | -608.9% | 41.4% | ||
| Q3 25 | -907.4% | 38.6% | ||
| Q2 25 | -1020.1% | 41.9% | ||
| Q1 25 | -1222.0% | 40.3% | ||
| Q4 24 | -1165.3% | 32.8% | ||
| Q3 24 | -1146.9% | 14.8% | ||
| Q2 24 | -1228.3% | 36.6% | ||
| Q1 24 | -1124.3% | 45.9% |
| Q4 25 | -541.1% | 37.6% | ||
| Q3 25 | -803.1% | 29.7% | ||
| Q2 25 | -899.4% | 32.2% | ||
| Q1 25 | -1023.3% | 31.1% | ||
| Q4 24 | -899.6% | 26.2% | ||
| Q3 24 | 10574.7% | 11.8% | ||
| Q2 24 | -1115.7% | 29.4% | ||
| Q1 24 | -995.8% | 36.7% |
| Q4 25 | $-1.86 | $0.94 | ||
| Q3 25 | $-1.78 | $0.75 | ||
| Q2 25 | $-1.93 | $0.87 | ||
| Q1 25 | $-1.55 | $0.77 | ||
| Q4 24 | $-1.44 | $0.64 | ||
| Q3 24 | $16.22 | $0.28 | ||
| Q2 24 | $-1.69 | $0.73 | ||
| Q1 24 | $-1.45 | $0.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $284.4M |
| Total Assets | $1.3B | $2.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | — | ||
| Q3 25 | $92.7M | — | ||
| Q2 25 | $80.9M | — | ||
| Q1 25 | $79.0M | — | ||
| Q4 24 | $76.2M | — | ||
| Q3 24 | $253.7M | — | ||
| Q2 24 | $84.5M | — | ||
| Q1 24 | $118.8M | — |
| Q4 25 | $1.2B | $284.4M | ||
| Q3 25 | $1.3B | $270.1M | ||
| Q2 25 | $1.4B | $252.6M | ||
| Q1 25 | $1.5B | $201.3M | ||
| Q4 24 | $1.5B | $185.5M | ||
| Q3 24 | $1.6B | $193.1M | ||
| Q2 24 | $660.5M | $177.5M | ||
| Q1 24 | $743.9M | $168.7M |
| Q4 25 | $1.3B | $2.7B | ||
| Q3 25 | $1.4B | $2.6B | ||
| Q2 25 | $1.5B | $2.6B | ||
| Q1 25 | $1.6B | $2.6B | ||
| Q4 24 | $1.7B | $2.5B | ||
| Q3 24 | $1.8B | $2.5B | ||
| Q2 24 | $773.1M | $2.5B | ||
| Q1 24 | $849.7M | $2.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $43.8M |
| Free Cash FlowOCF − Capex | $-97.3M | $41.3M |
| FCF MarginFCF / Revenue | -487.5% | 125.1% |
| Capex IntensityCapex / Revenue | 5.6% | 7.6% |
| Cash ConversionOCF / Net Profit | — | 3.53× |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $69.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $43.8M | ||
| Q3 25 | $-88.2M | $30.2M | ||
| Q2 25 | $-77.1M | $-5.0M | ||
| Q1 25 | $-111.5M | $4.8M | ||
| Q4 24 | $-133.2M | $34.6M | ||
| Q3 24 | $-84.2M | $10.2M | ||
| Q2 24 | $-72.6M | $9.3M | ||
| Q1 24 | $-99.9M | $2.3M |
| Q4 25 | $-97.3M | $41.3M | ||
| Q3 25 | $-89.7M | $29.6M | ||
| Q2 25 | $-78.0M | $-5.7M | ||
| Q1 25 | $-112.3M | $4.3M | ||
| Q4 24 | $-134.1M | $32.9M | ||
| Q3 24 | $-84.6M | $10.0M | ||
| Q2 24 | $-72.7M | $9.2M | ||
| Q1 24 | $-100.0M | $2.0M |
| Q4 25 | -487.5% | 125.1% | ||
| Q3 25 | -696.5% | 87.8% | ||
| Q2 25 | -626.2% | -17.5% | ||
| Q1 25 | -1286.4% | 15.5% | ||
| Q4 24 | -1250.1% | 120.0% | ||
| Q3 24 | -944.2% | 36.7% | ||
| Q2 24 | -844.4% | 32.8% | ||
| Q1 24 | -1221.2% | 7.9% |
| Q4 25 | 5.6% | 7.6% | ||
| Q3 25 | 12.1% | 1.8% | ||
| Q2 25 | 7.0% | 2.3% | ||
| Q1 25 | 8.8% | 1.8% | ||
| Q4 24 | 9.0% | 6.3% | ||
| Q3 24 | 4.7% | 1.1% | ||
| Q2 24 | 1.8% | 0.4% | ||
| Q1 24 | 1.7% | 1.0% |
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.01× | ||
| Q2 25 | — | -0.47× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | — | 4.83× | ||
| Q3 24 | -0.09× | 3.19× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
